ArticleBMC cancer2025

TOPK promotes immune suppression in kidney renal clear cell carcinoma and emerges as a prognostic and therapeutic target.

Zeyuan Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.